Studies in breast and lung cancer models have linked RCC1 overexpression to increased tumor invasiveness and resistance to apoptosis, indicating that RCC1 may be crucial for cancer cell survival under therapeutic stress [17,18]. The gene discussed is RCC1; the disease is lung carcinoma.